Search for: "Sanofi S A" Results 101 - 120 of 933
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 May 2023, 9:43 am by Rose Hughes
Amgen sued Sanofi for infringement and Sanofi counterclaimed that Amgen's patents were invalid for lack of enablement. [read post]
17 Jan 2012, 10:31 am
Li worked from 2006 through 2011 at Sanofi's U.S. headquarters in Bridgewater, researching potential future drugs.She admitted to accessing, downloading and making available for sale on Abby's website internal Sanofi database information on compounds the company says were trade secrets.Li will be sentenced on April 23rd. [read post]
23 May 2023, 2:37 pm by Holman
Sanofi, including Dennis’s prompt response. [read post]
7 May 2020, 5:29 am by Annsley Merelle Ward
The order only restrained Apotex from acts constituting an exploitation of Sanofis patent (including importation, manufacture and supply of the clopidogrel products) but did not in terms restrain Apotex from applying for PBS listing for the clopidogrel products. [read post]
15 Mar 2016, 5:09 pm by Kevin LaCroix
Sanofi,1 the Second Circuit interpreted and applied for the first time the Supreme Court’s decision in Omnicare Inc. v. [read post]
13 Nov 2013, 8:40 pm
Pfizer’s filing date is March 1, 1996; Pfizer thus bore the burden of proving a date of conception earlier than the Sanofi benefit date. [read post]
21 Mar 2023, 8:17 pm by Patent Docs
Noonan -- The Supreme Court's decision to grant certiorari in Amgen v. [read post]
19 Mar 2023, 9:32 pm by Patent Docs
Noonan -- The Supreme Court's decision to grant certiorari in Amgen v. [read post]
27 Mar 2011, 6:28 pm
According to the lawsuit, the late Samuel Hunter was participating in a clinical trial of sanofi's proposed cancer drug, Aflibercept. [read post]
10 Sep 2009, 4:53 pm
The appellate ruling comes too late to keep generic manufacturers of the colon cancer drug Eloxatin out of the market, but the Federal Circuit found that a lower court judge interpreted Sanofi's patent incorrectly when he cleared the way for its rivals. [read post]
21 Jul 2009, 9:28 pm
Patent Nos. 5,389,618 and RE 38,743, cover Sanofi's anti-clotting drug, Lovenox ®. [read post]
18 Dec 2014, 4:43 pm
That’s what Diane Ponte, a paralegal in the French company’s New Jersey office, claims in the whistle-blower lawsuit she filed against Sanofi. [read post]
18 Oct 2011, 10:43 am by Dennis Crouch
Cir. 2011) The case focuses on Sanofi's patent covering clopidrogrel bisulfate tablets sold under the trade name Plavix. ($4.5 billion in annual sales). [read post]
10 Dec 2006, 12:57 pm
Cir. 2006) Generic manufacturer Apotex wants to make something similar to Sanofi's Plavix (clopidogrel bisulfate) and filed an ANDA alleging that Sanofi's patents were invalid. [read post]
The IP High Court held Amgen’s patent valid on December 27, 2018 in the invalidity case, and then found Sanofis manufacture and sale of Praluent® as infringing Amgen’s patent, which was reaffirmed to be valid, on October 30, 2019. [read post]